Sareum Holdings plc

Headquarters: Cambridge, United Kingdom

Employees: 6

CEO: Dr. Tim J. Mitchell Ph.D.

show_chart LSE: SAR

Market Cap

£4.27 Billion

GBP as of April 1, 2022

US$5.60 Billion

history Market Cap History

Sareum Holdings plc market capitalization over time

Evolution of Sareum Holdings plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Sareum Holdings plc

Detailed Description

Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.

Stocks & Indices

Sareum Holdings plc has the following listings and related stock indices.

Stock: LSE: SAR



Langford Arch

Unit 2A London Road Pampisford

Cambridge, CB22 3FX

United Kingdom

Phone: 44 1223 497 700

Fax: 44 1223 497 701